Microbial Ecosystem Therapeutics 4 (MET-4) + Pembrolizumab & Head & Neck squamous cell carcinoma (HNSCC)

The randomized clinical phase II treatment trial NCT05743777 - PROMOTE-HN - Microbial Ecosystem Therapeutics 4 (MET-4) + Pembrolizumab vs Pembrolizumab & Head & Neck squamous cell carcinoma (HNSCC) has been withdrawn
Perl et al. 2025 Med 6: 100773

see also:
Anti-PD-1 Antibodies / PD-1 Inhibitors + Microbiome-based therapeutics & Head & Neck squamous cell carcinoma (HNSCC)
Head & Neck squamous cell carcinoma (HNSCC) & Drugs/Treatments
Immune Checkpoint Inhibitors (ICIs) Therapy (to improve) & Drugs/Treatments